Aug 26, 2025 10:29PM
Sep 5, 2024 11:54AM
Feb 15, 2023 06:00AM
Jan 25, 2023 06:00AM
Dec 23, 2022 06:00AM
Dec 5, 2022 06:00AM
Oct 4, 2022 06:00AM Immuron Executes Travelan Clinical Trial Agreement with US-based Pharmaron
Jul 26, 2022 06:00AM
May 11, 2022 06:00AM
May 5, 2022 08:22PM
Apr 27, 2022 06:00AM
Apr 19, 2022 07:33AM
Nov 10, 2021 06:00AM
Jan 11, 2021 06:00AM Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021 Virtual Conference
Nov 24, 2020 06:00AM
Nov 11, 2020 06:00AM
Oct 12, 2020 06:00AM
Jul 23, 2020 12:45PM
Jul 21, 2020 08:47AM
Jul 21, 2020 08:45AM
Jul 21, 2020 07:00AM Immuron Reports Neutralizing Activity Against SARS-CoV-2 Key Points
Jul 20, 2020 06:00AM
Jun 19, 2020 06:00AM
Jun 9, 2020 06:00AM
Apr 20, 2020 06:00AM
Mar 25, 2020 06:00AM
Mar 3, 2020 07:00AM
Feb 3, 2020 07:30AM Immuron’s Technology Platform of Treatments in the Age of the Coronavirus Outbreak
Feb 3, 2020 07:30AM
Jan 28, 2020 08:30AM
Nov 21, 2019 07:08AM
Nov 21, 2019 07:00AM
Nov 4, 2019 11:30AM
Oct 2, 2019 09:00AM
Aug 16, 2019 06:00AM Immuron to Commence Non-Deal Investor Roadshow
Aug 8, 2019 12:01PM
Aug 8, 2019 12:00PM
Jul 17, 2019 06:00AM
Jul 17, 2019 06:00AM
Jul 16, 2019 04:32PM
Jul 16, 2019 04:31PM
Jul 16, 2019 06:00AM Immuron North American revenue surges by 52% in FY19
Jun 25, 2019 06:00AM
May 30, 2019 08:00AM
May 23, 2019 09:10PM
May 23, 2019 04:46PM
May 23, 2019 04:45PM
Apr 30, 2019 02:36PM
Apr 11, 2019 10:02AM Immuron (IMRN) Receives U.S. Patent on Drug Composition to Treat Clostridium difficile
Apr 11, 2019 10:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All